Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 3
1952 2
1953 5
1954 5
1955 4
1956 4
1957 4
1958 3
1959 5
1961 1
1963 99
1964 172
1965 69
1966 1
1967 3
1968 7
1969 10
1970 5
1971 2
1972 7
1973 4
1974 7
1975 4
1976 10
1977 9
1978 8
1979 3
1980 2
1981 7
1982 1
1983 1
1984 8
1985 4
1986 3
1987 7
1988 7
1989 8
1990 7
1991 5
1992 13
1993 13
1994 18
1995 9
1996 19
1997 22
1998 28
1999 46
2000 43
2001 41
2002 70
2003 51
2004 63
2005 84
2006 68
2007 116
2008 123
2009 102
2010 123
2011 159
2012 149
2013 150
2014 228
2015 260
2016 240
2017 260
2018 273
2019 270
2020 288
2021 320
2022 141
Text availability
Article attribute
Article type
Publication date

Search Results

3,904 results
Results by year
Filters applied: . Clear all The following terms were not found in PubMed: Worapree, Maneesoonthorn
Page 1
Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study.
Sandborn WJ, Feagan BG, Hanauer S, Vermeire S, Ghosh S, Liu WJ, Petersen A, Charles L, Huang V, Usiskin K, Wolf DC, D'Haens G. Sandborn WJ, et al. J Crohns Colitis. 2021 Jul 5;15(7):1120-1129. doi: 10.1093/ecco-jcc/jjab012. J Crohns Colitis. 2021. PMID: 33438008 Free PMC article. Clinical Trial.
BACKGROUND AND AIMS: This analysis examined the long-term safety and efficacy of ozanimod in patients with moderately to severely active ulcerative colitis [UC] with 4 years of follow-up in the phase 2 TOUCHSTONE open-label extension [OLE]. METHODS: Patients receiving plac …
BACKGROUND AND AIMS: This analysis examined the long-term safety and efficacy of ozanimod in patients with moderately to severely active ulc …
Occipital lobe seizures and epilepsies.
Adcock JE, Panayiotopoulos CP. Adcock JE, et al. J Clin Neurophysiol. 2012 Oct;29(5):397-407. doi: 10.1097/WNP.0b013e31826c98fe. J Clin Neurophysiol. 2012. PMID: 23027097 Review.
In cryptogenic/symptomatic OLE, unilateral posterior EEG slowing is more common than occipital spikes. In neurosurgical series of symptomatic OLE, interictal EEG abnormalities are rarely strictly occipital. ...
In cryptogenic/symptomatic OLE, unilateral posterior EEG slowing is more common than occipital spikes. In neurosurgical series of sym …
Long-term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program.
Bussel JB, Arnold DM, Boxer MA, Cooper N, Mayer J, Zayed H, Tong S, Duliege AM. Bussel JB, et al. Am J Hematol. 2019 May;94(5):546-553. doi: 10.1002/ajh.25444. Epub 2019 Mar 13. Am J Hematol. 2019. PMID: 30784097 Free PMC article. Clinical Trial.
The long-term safety and efficacy of fostamatinib were evaluated in a follow-on, open-label extension (OLE) study. Patients received double-blind fostamatinib in the randomized trials, and responders continued the same dose, 100 to 150 mg BID, in the OLE study. ...E …
The long-term safety and efficacy of fostamatinib were evaluated in a follow-on, open-label extension (OLE) study. Patients received …
Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randomised controlled trial.
Lockyer S, Rowland I, Spencer JPE, Yaqoob P, Stonehouse W. Lockyer S, et al. Eur J Nutr. 2017 Jun;56(4):1421-1432. doi: 10.1007/s00394-016-1188-y. Epub 2016 Mar 7. Eur J Nutr. 2017. PMID: 26951205 Free PMC article. Clinical Trial.
We conducted a randomised, double-blind, controlled, crossover trial to investigate the effects of a phenolic-rich olive leaf extract (OLE) on BP and a number of associated vascular and metabolic measures. ...CONCLUSION: Our data support previous research, suggesting that …
We conducted a randomised, double-blind, controlled, crossover trial to investigate the effects of a phenolic-rich olive leaf extract (OL …
Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study.
Zouboulis CC, Okun MM, Prens EP, Gniadecki R, Foley PA, Lynde C, Weisman J, Gu Y, Williams DA, Jemec GBE. Zouboulis CC, et al. J Am Acad Dermatol. 2019 Jan;80(1):60-69.e2. doi: 10.1016/j.jaad.2018.05.040. Epub 2018 Jun 1. J Am Acad Dermatol. 2019. PMID: 29860040 Clinical Trial.
METHODS: The durations of the PIONEER I/II periods A, B, and OLE were 12, 24, and 52 or more weeks, respectively. Patients who entered the OLE and received ADA (40 mg every week continuously) and responders plus partial responders (PRRs) were evaluated. ...LIMITATIO …
METHODS: The durations of the PIONEER I/II periods A, B, and OLE were 12, 24, and 52 or more weeks, respectively. Patients who entere …
Adult occipital lobe epilepsy: 12-years on.
Angus-Leppan H, Clay TA. Angus-Leppan H, et al. J Neurol. 2021 Oct;268(10):3926-3934. doi: 10.1007/s00415-021-10557-y. Epub 2021 Apr 26. J Neurol. 2021. PMID: 33900448
METHODS: 24 adult OLE patients identified over 12 months from 1548 patients in a neurologist's service were followed over 12 years. ...CONCLUSION: Adult OLE accounted for 7.7% of focal epilepsies in this cohort, misdiagnosed or misclassified in 40%. ...
METHODS: 24 adult OLE patients identified over 12 months from 1548 patients in a neurologist's service were followed over 12 years. . …
Tolvaptan in ADPKD Patients With Very Low Kidney Function.
Torres VE, Gansevoort RT, Perrone RD, Chapman AB, Ouyang J, Lee J, Japes H, Nourbakhsh A, Wang T. Torres VE, et al. Kidney Int Rep. 2021 Jun 9;6(8):2171-2178. doi: 10.1016/j.ekir.2021.05.037. eCollection 2021 Aug. Kidney Int Rep. 2021. PMID: 34386666 Free PMC article.
This post hoc analysis retrospectively investigated eGFR decline in REPRISE versus an open-label, phase 3b extension trial (open-label extension [OLE] NCT02251275) in subjects who received placebo in REPRISE and tolvaptan in OLE with eGFR 15 to 24 and 25 to 29 ml/mi …
This post hoc analysis retrospectively investigated eGFR decline in REPRISE versus an open-label, phase 3b extension trial (open-label exten …
Ole e 3, a Candidate for in vivo Diagnosis of Polcalcin Sensitization.
Moya R, González-Ruiz A, Beitia JM, Carnés J, López-Matas MÁ. Moya R, et al. Int Arch Allergy Immunol. 2021;182(6):465-473. doi: 10.1159/000512303. Epub 2021 Jan 18. Int Arch Allergy Immunol. 2021. PMID: 33461195
Ole e 3 enabled diagnosis of polcalcin-sensitized patients, and a good correlation was revealed with ImmunoCAP. A 50% inhibition in IgE binding was obtained with 2.8 ng of Ole e 3 for rBet v 4 and 3.9 ng for rPhl p 7. DISCUSSION/CONCLUSION: Native Ole e 3 was …
Ole e 3 enabled diagnosis of polcalcin-sensitized patients, and a good correlation was revealed with ImmunoCAP. A 50% inhibition in I …
Transcriptomics of Listeria monocytogenes Treated With Olive Leaf Extract.
Liu Y, Fang T, Suo Y, Gao S, Baranzoni GM, Armstrong CM. Liu Y, et al. Front Microbiol. 2021 Dec 23;12:782116. doi: 10.3389/fmicb.2021.782116. eCollection 2021. Front Microbiol. 2021. PMID: 35003011 Free PMC article.
To help identify the cellular mechanisms important for conveying these beneficial traits, RNA-Seq was used to study the transcriptome of L. monocytogenes upon exposure to a sublethal level of OLE. Results obtained from cells cultured both with and without OLE at two …
To help identify the cellular mechanisms important for conveying these beneficial traits, RNA-Seq was used to study the transcriptome of L. …
Structure of a bacterial OapB protein with its OLE RNA target gives insights into the architecture of the OLE ribonucleoprotein complex.
Yang Y, Harris KA, Widner DL, Breaker RR. Yang Y, et al. Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):e2020393118. doi: 10.1073/pnas.2020393118. Proc Natl Acad Sci U S A. 2021. PMID: 33619097 Free PMC article.
These biological functions have been shown to require the formation of a ribonucleoprotein (RNP) complex including at least two protein partners: OLE-associated protein A (OapA) and OLE-associated protein B (OapB). OapB directly binds OLE RNA with high-affini …
These biological functions have been shown to require the formation of a ribonucleoprotein (RNP) complex including at least two protein part …
3,904 results